Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Anna Ståhl & Elisabeth Westerdahl. (2020) Postoperative Physical Therapy to Prevent Hospital-acquired Pneumonia in Patients Over 80 Years Undergoing Hip Fracture Surgery—A Quasi-experimental Study. Clinical Interventions in Aging 15, pages 1821-1829.
Read now
Read now
Simon Athlin, Christer Lidman, Anders Lundqvist, Pontus Naucler, Anna C. Nilsson, Carl Spindler, Kristoffer Strålin & Jonas Hedlund. (2018) Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017. Infectious Diseases 50:4, pages 247-272.
Read now
Read now
Lionel A. Mandell. (2015) Community-acquired pneumonia: An overview. Postgraduate Medicine 127:6, pages 607-615.
Read now
Read now
Vesna Cvitkovic Spik, Bojana Beovic, Marko Pokorn, Ana Drole Torkar, Darja Vidmar, Lea Papst, Katja Seme, Rok Kogoj & Manica Müller Premru. (2013) Improvement of pneumococcal pneumonia diagnostics by the use of rt-PCR on plasma and respiratory samples. Scandinavian Journal of Infectious Diseases 45:10, pages 731-737.
Read now
Read now
Anna Lange Jendeberg, Kristoffer Strålin & Olof Hultgren. (2013) Antimicrobial peptide plasma concentrations in patients with community-acquired pneumonia. Scandinavian Journal of Infectious Diseases 45:6, pages 432-437.
Read now
Read now
Simon Athlin & Kristoffer Strålin. (2013) The Binax NOW Streptococcus pneumoniae test applied on nasopharyngeal aspirates to support pneumococcal aetiology in community-acquired pneumonia. Scandinavian Journal of Infectious Diseases 45:6, pages 425-431.
Read now
Read now
Susann Skovbjerg, Ann Söderström, Lars Hynsjö, Birgitta Henriques Normark, Karl Ekdahl & Christina Åhrén. (2013) Low rate of pneumococci non-susceptible to penicillin in healthy Swedish toddlers. Scandinavian Journal of Infectious Diseases 45:4, pages 279-284.
Read now
Read now
Articles from other publishers (39)
Kingkarn Wijit, Paveena Sonthisombat & Jaruwan Diewsurin. (2023) A score to predict Pseudomonas aeruginosa infection in older patients with community-acquired pneumonia. BMC Infectious Diseases 23:1.
Crossref
Crossref
Oliver Van Hecke, Lars Bjerrum, Ivan Gentile, Rogier Hopstaken, Hasse Melbye, Andreas Plate, Jan Y. Verbakel, Carl Llor & Annamaria Staiano. (2023) Guidance on C-reactive protein point-of-care testing and complementary strategies to improve antibiotic prescribing for adults with lower respiratory tract infections in primary care. Frontiers in Medicine 10.
Crossref
Crossref
Simon Athlin, Anders Magnuson, Carl Spindler, Jonas Hedlund, Kristoffer Strålin & Pontus Nauclér. (2022) Pneumococcal urinary antigen testing for antimicrobial guidance in community-acquired pneumonia–A register-based cohort study. Journal of Infection 85:2, pages 167-173.
Crossref
Crossref
Rosa Stalteri Mastrangelo, Nancy Santesso, Antonio Bognanni, Andrea Darzi, Samer Karam, Thomas Piggott, Tejan Baldeh, Finn Schünemann, Matthew Ventresca, Gian Paolo Morgano, Lorenzo Moja, Mark Loeb & Holger Schunemann. (2021) Consideration of antimicrobial resistance and contextual factors in infectious disease guidelines: a systematic survey. BMJ Open 11:7, pages e046097.
Crossref
Crossref
Mārcis Leja & Uga Dumpis. (2019) What Would the Screen-and-Treat Strategy for Helicobacter pylori Mean in Terms of Antibiotic Consumption?. Digestive Diseases and Sciences 65:6, pages 1632-1642.
Crossref
Crossref
Abel J. Triana, Jorge L. Molinares, Gaspar Del Rio‐Pertuz, Jose L. Meza, Orlando Ariza‐Bolívar, Andrea Robledo‐Solano & Jorge Acosta‐Reyes. (2020) Clinical practice guidelines for the management of community‐acquired pneumonia: A critical appraisal using the AGREE II instrument. International Journal of Clinical Practice 74:5.
Crossref
Crossref
Lars Ljungström, Rune Andersson & Gunnar Jacobsson. (2019) Incidences of community onset severe sepsis, Sepsis-3 sepsis, and bacteremia in Sweden – A prospective population-based study. PLOS ONE 14:12, pages e0225700.
Crossref
Crossref
Emil Ekbom, Jennifer Quint, Linus Schöler, Andrei Malinovschi, Karl Franklin, Mathias Holm, Kjell Torén, Eva Lindberg, Deborah Jarvis & Christer Janson. (2019) Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia. BMC Pulmonary Medicine 19:1.
Crossref
Crossref
Inger van Heijl, Valentijn A. Schweitzer, C. H. Edwin Boel, Jan Jelrik Oosterheert, Susanne M. Huijts, Wendelien Dorigo-Zetsma, Paul D. van der Linden, Marc J. M. Bonten & Cornelis H. van Werkhoven. (2019) Confounding by indication of the safety of de-escalation in community-acquired pneumonia: A simulation study embedded in a prospective cohort. PLOS ONE 14:9, pages e0218062.
Crossref
Crossref
Chun Lin, Huanzhu Chen, Ping He, Yazhen Li, Changwen Ke & Xiaoyang Jiao. (2019) Etiology and characteristics of community-acquired pneumonia in an influenza epidemic period. Comparative Immunology, Microbiology and Infectious Diseases 64, pages 153-158.
Crossref
Crossref
Carl Llor, Almudena Pérez, Eugenia Carandell, Anna García-Sangenís, Javier Rezola, Marian Llorente, Salvador Gestoso, Francesc Bobé, Miguel Román-Rodríguez, Josep M. Cots, Silvia Hernández, Jordi Cortés, Marc Miravitlles & Rosa Morros. (2019) Efficacy of high doses of penicillin versus amoxicillin in the treatment of uncomplicated community acquired pneumonia in adults. A non-inferiority controlled clinical trial. Atención Primaria 51:1, pages 32-39.
Crossref
Crossref
Amir Ramezani, Lars Eng, Maria V. Turkina, Annette Theodorsson & Fariba Nayeri. (2018) A Sputum Screening Test to Rule Out Pneumonia at an Early Stage With High Negative Predictive Value. Point of Care: The Journal of Near-Patient Testing & Technology 17:4, pages 101-108.
Crossref
Crossref
John Thegerström, Viktor Månsson, Kristian Riesbeck & Fredrik Resman. (2018) Benzylpenicillin versus wide-spectrum beta-lactam antibiotics as empirical treatment of Haemophilus influenzae-associated lower respiratory tract infections in adults; a retrospective propensity score-matched study. European Journal of Clinical Microbiology & Infectious Diseases 37:9, pages 1761-1775.
Crossref
Crossref
Niclas Johansson, Carl Spindler, John Valik & Veronica Vicente. (2018) Developing a decision support system for patients with severe infection conditions in pre-hospital care. International Journal of Infectious Diseases 72, pages 40-48.
Crossref
Crossref
Hassan Jahanihashemi, Mona Babaie, Soroush Bijani, Maryam Bazzazan & Behzad Bijani. (2018) Poverty as an independent risk factor for in-hospital mortality in community-acquired pneumonia: A study in a developing country population. International Journal of Clinical Practice 72:5, pages e13085.
Crossref
Crossref
Gertrud Baunbæk Egelund, Andreas Vestergaard Jensen, Stine Bang Andersen, Pelle Trier Petersen, Bjarne Ørskov Lindhardt, Christian von Plessen, Gernot Rohde & Pernille Ravn. (2017) Penicillin treatment for patients with Community-Acquired Pneumonia in Denmark: a retrospective cohort study. BMC Pulmonary Medicine 17:1.
Crossref
Crossref
Konstantinos Z. Vardakas, Kyriakos K. Trigkidis, Katerina N. Apiranthiti & Matthew E. Falagas. (2017) The dilemma of monotherapy or combination therapy in community‐acquired pneumonia. European Journal of Clinical Investigation 47:12.
Crossref
Crossref
M.A. Tazón-Varela, H. Alonso-Valle, P. Muñoz-Cacho, J. Gallo-Terán, X. Piris-García & L.A. Pérez-Mier. (2017) Aumento de microorganismos no habituales en la neumonía adquirida en la comunidad. SEMERGEN - Medicina de Familia 43:6, pages 437-444.
Crossref
Crossref
Christelle Elias, Lorenzo Moja, Dominik Mertz, Mark Loeb, Gilles Forte & Nicola Magrini. (2017) Guideline recommendations and antimicrobial resistance: the need for a change. BMJ Open 7:7, pages e016264.
Crossref
Crossref
Douwe F. Postma, Cornelis H. van Werkhoven & Jan Jelrik Oosterheert. (2017) Community-acquired pneumonia requiring hospitalization. Current Opinion in Pulmonary Medicine 23:3, pages 204-210.
Crossref
Crossref
Mar Masiá, Sergio Padilla, Victoria Ortiz de la Tabla, Matilde González, Cristina Bas & Félix Gutiérrez. (2017) Procalcitonin for selecting the antibiotic regimen in outpatients with low-risk community-acquired pneumonia using a rapid point-of-care testing: A single-arm clinical trial. PLOS ONE 12:4, pages e0175634.
Crossref
Crossref
K.Z. Vardakas, K.K. Trigkidis & M.E. Falagas. (2017) Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis. Clinical Microbiology and Infection 23:4, pages 234-241.
Crossref
Crossref
Giulio DiDiodato, Leslie McArthur, Joseph Beyene, Marek Smieja & Lehana Thabane. (2015) Can an antimicrobial stewardship program reduce length of stay of immune-competent adult patients admitted to hospital with diagnosis of community-acquired pneumonia? Study protocol for pragmatic controlled non-randomized clinical study. Trials 16:1.
Crossref
Crossref
Jan C Holter, Fredrik Müller, Ola Bjørang, Helvi H Samdal, Jon B Marthinsen, Pål A Jenum, Thor Ueland, Stig S Frøland, Pål Aukrust, Einar Husebye & Lars Heggelund. (2015) Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway. BMC Infectious Diseases 15:1.
Crossref
Crossref
Helena Alpkvist, Simon Athlin, Pontus Nauclér, Björn Herrmann, Guma Abdeldaim, Hans-Christian Slotved, Jonas Hedlund & Kristoffer Strålin. (2015) Clinical and Microbiological Factors Associated with High Nasopharyngeal Pneumococcal Density in Patients with Pneumococcal Pneumonia. PLOS ONE 10:10, pages e0140112.
Crossref
Crossref
Amelia Cutts, Katy McAllister & James D. Chalmers. (2015) Empirical Antibiotic Treatment for Community-acquired Pneumonia. Clinical Pulmonary Medicine 22:4, pages 192-198.
Crossref
Crossref
Viktorija Tomic & Michael J Dowzicky. (2014) Regional and global antimicrobial susceptibility among isolates of Streptococcus pneumoniae and Haemophilus influenzae collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) from 2009 to 2012 and comparison with previous years of T.E.S.T. (2004-2008). Annals of Clinical Microbiology and Antimicrobials 13:1.
Crossref
Crossref
Simon Athlin, Margit Kaltoft, Hans-Christian Slotved, Björn Herrmann, Hans Holmberg, Helle Bossen Konradsen & Kristoffer Strålin. (2014) Association between Serotype-Specific Antibody Response and Serotype Characteristics in Patients with Pneumococcal Pneumonia, with Special Reference to Degree of Encapsulation and Invasive Potential. Clinical and Vaccine Immunology 21:11, pages 1541-1549.
Crossref
Crossref
Daniel M. Musher & Anna R. Thorner. (2014) Community-Acquired Pneumonia. New England Journal of Medicine 371:17, pages 1619-1628.
Crossref
Crossref
Smita Pakhale, Sunita Mulpuru, Theo JM Verheij, Michael M Kochen, Gernot GU Rohde & Lise M Bjerre. (2014) Antibiotics for community-acquired pneumonia in adult outpatients. Cochrane Database of Systematic Reviews 2014:10.
Crossref
Crossref
June Utnes Høgli, Lars Småbrekke & Beate Hennie Garcia. (2014) MAT‐CAP: a novel medication assessment tool to explore adherence to clinical practice guidelines in community‐acquired pneumonia. Pharmacoepidemiology and Drug Safety 23:9, pages 933-941.
Crossref
Crossref
M. S. Abers & D. M. Musher. (2014) Clinical prediction rules in community-acquired pneumonia: lies, damn lies and statistics. QJM 107:7, pages 595-596.
Crossref
Crossref
Johannes B.J. Scholte, Walther N.K.A. van Mook & Catharina F.M. Linssen. (2014) Surveillance cultures in healthcare-associated pneumonia. Current Opinion in Pulmonary Medicine 20:3, pages 259-271.
Crossref
Crossref
Kristoffer Strålin, Björn Herrmann, Guma Abdeldaim, Per Olcén, Hans Holmberg & Paula Mölling. (2014)
Comparison of Sputum and Nasopharyngeal Aspirate Samples and of the PCR Gene Targets
lytA
and Spn9802 for Quantitative PCR for Rapid Detection of Pneumococcal Pneumonia
. Journal of Clinical Microbiology 52:1, pages 83-89.
Crossref
Crossref
Carl Llor, Javier Arranz, Rosa Morros, Anna García-Sangenís, Helena Pera, Joan Llobera, Mireia Guillén-Solà, Eugenia Carandell, Jesús Ortega, Silvia Hernández & Marc Miravitlles. (2013) Efficacy of high doses of oral penicillin versus amoxicillin in the treatment of adults with non-severe pneumonia attended in the community: study protocol for a randomised controlled trial. BMC Family Practice 14:1.
Crossref
Crossref
O. Henig, D. Yahav, L. Leibovici & M. Paul. (2013) Guidelines for the treatment of pneumonia and urinary tract infections: evaluation of methodological quality using the Appraisal of Guidelines, Research and Evaluation II instrument. Clinical Microbiology and Infection 19:12, pages 1106-1114.
Crossref
Crossref
Jane C. Deng. (2013) Viral-bacterial interactions-therapeutic implications. Influenza and Other Respiratory Viruses 7, pages 24-35.
Crossref
Crossref
Daniel M. Musher, Ingrid L. Roig, Guillermo Cazares, Charles E. Stager, Nancy Logan & Hossam Safar. (2013) Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: Results of a one-year study. Journal of Infection 67:1, pages 11-18.
Crossref
Crossref
Guma M.K. Abdeldaim, Kristoffer Strålin, Per Olcén, Jonas Blomberg, Paula Mölling & Björn Herrmann. (2013) Quantitative fucK gene polymerase chain reaction on sputum and nasopharyngeal secretions to detect Haemophilus influenzae pneumonia. Diagnostic Microbiology and Infectious Disease 76:2, pages 141-146.
Crossref
Crossref